The contact lens and myopia progression (CLAMP) study: design and baseline data. Walline JJ, Mutti DO, Jones LA, Rah MJ, Nichols KK, Watson R, Zadnik K. Optom Vis Sci 2001;78:223–233.

Abstract

Although previous contact lens myopia control studies indicate that rigid contact lenses slow the progression of myopia in children, they have all suffered from limitations. The Contact Lens and Myopia Progression (CLAMP) Study addresses the limitations of previous studies and attempts to correct them by implementing alternative study designs. The CLAMP Study also measures all ocular components to examine the potential mechanism of treatment effect. Eligible children were fitted with rigid gas-permeable contact lenses and enrolled in a run-in period to determine whether they were able to adapt to rigid contact lens wear. Subjects who successfully completed the run-in period were randomly assigned to wear rigid contact lenses or soft contact lenses for the remainder of the 3-year study. The primary outcome measure will be the 3-year change in cycloplegic autorefraction; the secondary outcome measures will include the 3-year change in axial length, peripheral autorefraction, crystalline lens curvatures, corneal curvature and thickness, accommodation, and intraocular pressure, which are being measured annually. Of the 148 eligible subjects who participated in the run-in period, 116 (78.4%) were able to adapt to rigid contact lens wear and were enrolled in the CLAMP Study. The mean age of the participants at the baseline visit was 10.5 years, and 59.5% were girls. At the randomization visit, the mean (±SD) spherical equivalent refractive error in the right eye was −2.09 ± 0.89 D, the mean central curvature of the right cornea by videokeratography was 44.5 ± 1.3 D, and the mean axial length of the right eye was 24.13 ± 0.71 mm. Four of five children aged 8 to 11 years old were able to adapt to rigid gas-permeable contact lens wear. The CLAMP Study aims to further clarify the effect of rigid gas-permeable contact lenses on myopia progression in children.—Thomas J. Liesegang